Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7797]

ASCO GI: Second-line ramucirumab added to standard chemotherapy delays disease progression, extends survival for patients with advanced colorectal cancer

ASCO GI: Second-line ramucirumab added to standard chemotherapy delays disease progression, extends survival for...

ASCO GI: Surgery may not be necessary for some patients with rectal cancer

ASCO GI: Surgery may not be necessary for some patients with rectal cancer

Disappointment over NHS England's bowel cancer drug decision

Disappointment over NHS England's bowel cancer drug decision

ASCO GI: Combining newer, more intensive first-line chemo with bevacizumab improves long-term outcome in advanced colorectal cancer

ASCO GI: Combining newer, more intensive first-line chemo with bevacizumab improves long-term outcome in advanced...

HPV integration 'hot spots' in cervical cancer identified by genome-wide profiling

HPV integration 'hot spots' in cervical cancer identified by genome-wide profiling

Afatinib shown to outdo chemo in extending survival in lung cancer with EGFR mutation

Afatinib shown to outdo chemo in extending survival in lung cancer with EGFR mutation

Armed virus shows promise as treatment for pancreatic cancer

Armed virus shows promise as treatment for pancreatic cancer

Study suggests that dopamine is a safe anti-angiogenic drug in cancer treatment

Study suggests that dopamine is a safe anti-angiogenic drug in cancer treatment

Researchers discover new genetic anomalies in lung cancer

Researchers discover new genetic anomalies in lung cancer

Targeting fatty acids may be treatment strategy for arthritis and leukaemia

Targeting fatty acids may be treatment strategy for arthritis and leukaemia

More from ecancer